References
- Becker RC, Sexton T, Smyth SS. Translational implications of platelets as vascular first responders. Circ Res. 2018;122(3):506–522.
- Eisinger F, Patzelt J, Langer HF. The Platelet Response to Tissue Injury. Front Med (Lausanne). 2018;5:317.
- Steinhubl SR. Historical observations on the discovery of platelets, platelet function testing and the first antiplatelet agent. Curr Drug Targets. 2011;12(12):1792–1804.
- Al-Mefty O, Marano G, Raiaraman S, et al. Transient ischemic attacks due to increased platelet aggregation and adhesiveness. Ultrastructural and functional correlation. J Neurosurg. 1979;50(4):449–453.
- Holiday PL, Mammen E, Gilroy J. Sticky platelet syndrome and cerebral infarction in young adults. Paper presented at: The Ninth International Joint Conference on Stroke and Cerebral Circulation. 1983; Phoenix, AZ, USA
- Rubenfire M, Blevins RD, Barnhart M, et al. Platelet hyperaggregability in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol. 1986;57(8):657–660.
- Mammen EF, Barnhart MI, Selik NR, et al. Sticky platelet syndrome”: a congenital platelet abnormality predisposing to thrombosis? Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(3):361–365.
- Mammen EF. Ten years´ experience with the “Sticky platelet syndrome“. Clin Appl Thromb Hemost. 1995;1(1):66–72.
- Mammen EF. Sticky platelet syndrome. Semin Thromb Hemost. 1999;25(4):361–365.
- Frenkel EP, Mammen EF. Sticky platelet syndrome and thrombocythemia. Hematol Oncol Clin North Am. 2003;17(1):63–83.
- Bick RL. Sticky platelet syndrome: a common cause of unexplained arterial and venous thrombosis. Clin Appl Thromb Hemost. 1998;4(2):77–81.
- Bick RL. Prothrombin G20210A mutation, antithrombin, heparin cofactor II, protein C, and protein S defects. Hematol Oncol Clin North Am. 2003;17(1):9–36.
- Bick RL, Hoppensteadt D. Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update. Clin Appl Thromb Hemost. 2005;11(1):1–13.
- Warrier I, Nigro M, Hillman C, et al. Platelet activation associated with stroke migraine in children. Thromb Haemost. 1991;65:772.
- Berg-Dammer E, Henkes H, Trobisch H, et al. Sticky platelet syndrome: a cause of neurovascular thrombosis and thrombo-embolism. Interv Neuroradiol. 1997;3(2):145–154.
- Chittoor SR, Elsehety AE, Roberts GF, et al. Sticky platelet syndrome: a case report and review of the literature. Clin Appl Thromb Hemost. 1998;4(4):280–284.
- Fodor M, Facskó A, Berényi E, et al. Transient visual loss triggered by scuba diving in a patient with a petrous epidermoid and combined thrombotic risk factors. Pathophysiol Haemost Thromb. 2007;36(6):311–314.
- Kannan S, Dhanasegaran S, Raji V. Recurrent Arterial Thrombosis In A Young Male: sticky Platelet Syndrome. The Internet J Hematol, 4(1), (2007). Available at: https://ispub.com/IJHE/4/1/6472#. Access date 2021 Sept 12
- Sand M, Mann B, Bechara FG, et al. Sticky platelet syndrome type II presenting with arterial microemboli in the fingers. Thromb Res. 2009;124(2):244.
- Chaturvedi S, Dzieczkowski JS. Protein S deficiency, activated protein C resistance and sticky platelet syndrome in a young woman with bilateral strokes. Cerebrovasc Dis. 1999;9(2):127–130.
- Lewerenz V, Burchardt T, Büchau A, et al. Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome. Hautarzt. 2004;55(4):379–381.
- El-Amm JM, Andersen J, Gruber SA. Sticky platelet syndrome: a manageable risk factor for posttransplant thromboembolic events. Am J Transplant. 2008;8(2):465.
- Bojalian MO, Akingba AG, Andersen JC, et al. Sticky platelet syndrome: an unusual presentation of arterial ischemia. Ann Vasc Surg. 2010;24(5):691.
- Ruiz-Argüelles GJ, López-Martínez B, Valdés-Tapia P, et al. Primary thrombophilia in Mexico. V. A comprehensive prospective study indicates that most cases are multifactorial. Am J Hematol. 2005;78(1):21–26.
- Kahles H, Trobisch H, Kehren H. Disseminated coronary occlusions and massive pulmonary embolism in a 40-year-old woman. Dtsch Med Wochenschr. 2006;131(13):672–675.
- Randhawa S, Van Stavern GP. Sticky platelet syndrome and anterior ischaemic optic neuropathy. Clin Experiment Ophthalmol. 2007;35(8):779–781.
- Mühlfeld AS, Ketteler M, Schwamborn K, et al. Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients. Am J Transplant. 2007;7(7):1865–1868.
- Mears KA, Van Stavern GP. Bilateral simultaneous anterior ischaemic optic neuropathy associated with sticky platelet syndrome. Br J Ophthalmol. 2009;93(7):885–886.
- Loeffelbein DJ, Baumann CM, Mücke T, et al. Sticky platelet syndrome as a possible cause for free flap failure–a case report. Microsurgery. 2010;30(6):466–468.
- Rac MWF, Minns Crawford N, Worley KC. Extensive thrombosis and first-trimester pregnancy loss caused by sticky platelet syndrome. Obstet Gynecol. 2011;117(2):501–503.
- Gehoff A, Kluge JG, Gehoff P, et al. Recurrent strokes under anticoagulation therapy: sticky platelet syndrome combined with a patent foramen ovale. J Cardiovasc Dis Res. 2011;2(1):68–70.
- Ruiz-Argüelles GJ, Alarcón-Urdaneta C, Calderón-García J, et al. Primary thrombophilia in México VIII: description of five kindreds of familial sticky platelet syndrome phenotype. Rev Hematol Mex. 2011;12:73–78.
- Yagmur E, Frank RD, Neulen J, et al. Platelet hyperaggregability is highly prevalent in patients with chronic kidney disease: an underestimated risk indicator of thromboembolic events. Clin Appl Thromb Hemost. 2015;21(2):132–138.
- Tekgündüz E, Demir M, Akyol Erikçi A, et al. Sticky platelet syndrome in patients with uninduced venous thrombosis. Turk J Haematol. 2013;30(1):48–52.
- Moncada B, Castillo-Martínez C, Ruiz-Argüelles GJ, et al. Sticky platelets syndrome: a frequent cause of primary thrombophilia. J Invest Dermatol. 2013;133(Suppl 1):S180.
- Velázquez-sánchez-de-cima S, Zamora-Ortiz G, Hernández-Reyes J, et al., Primary thrombophilia in México X: a prospective study of the treatment of the sticky platelet syndrome. Clin Appl Thromb Hemost. 2015;21(1):91–95.
- Šimonová R, Bartošová L, Chudý P, et al. Nine Kindreds of Familial Sticky Platelet Syndrome Phenotype. Clin Appl Thromb Hemost. 2013;19(4):395–401.
- Hayes C, Kitahara S, Tcherniantchouk O. Decreased Threshold of Aggregation to Low-Dose Epinephrine is Evidence of Platelet Hyperaggregability in Patients with Thrombosis. Hematol Rep. 2014;6(3):5326.
- Alsheekh AA, Puggioni A, Hingorani AP, et al. The sticky platelet syndrome during carotid endarterectomy. Ann Vasc Surg. 2015;29(6):1317.e9–e11.
- Ruiz-Delgado GJ, Cantero-Fortiz Y, Mendez-Huerta MA, et al. Primary Thrombophilia in Mexico XII: miscarriages Are More Frequent in People with Sticky Platelet Syndrome. Turk J Haematol. 2017;34(3):239–243.
- Solis-Jimenez F, Hinojosa-Heredia H, García-Covarrubias L, et al. Sticky platelet syndrome: an unrecognized cause of acute thrombosis and graft loss. Case Rep Nephrol. 2018;2018:3174897.
- Yagmur E, Bast E, Mühlfeld AS, et al. High prevalence of sticky platelet syndrome in patients with infertility and pregnancy loss. J Clin Med. 2019;8(9):1328.
- Kubisz P, Ruiz-Argüelles GJ, Stasko J, et al. Sticky platelet syndrome: history and future perspectives. Semin Thromb Hemost. 2014;40(5):526–534.
- Staško J, Bartošová L, Mýtnik M, et al. Are the platelets activated in sticky platelet syndrome? Thromb Res. 2011;128(1):96–97.
- Feng D, Lindpaintner K, Larson MG, et al. Increased platelet aggregability associated with platelet gpiiia pl a2 polymorphism. Arterioscler Thromb Vasc Biol. 1999;19(4):1142–1147.
- Johnson AD, Yanek LR, Chen MH, et al. Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genetics. 2010;42(7):608–613.
- Kubisz P, Ivanková J, Hollý P, et al. The glycoprotein IIIa PLA1/A2 polymorphism - a defect responsible for Sticky platelet syndrome? Clin Appl Thromb Hemost. 2006;12(1):117–119.
- Ruiz-Argüelles GJ, Garcés-Eisele J, Camacho-Alarcón C, et al. Primary thrombophilia in Mexico IX: the glycoprotein IIIa PLA1/A2 polymorphism is not associated with the sticky platelet syndrome phenotype. Clin Appl Thromb Hemost. 2012;19(6):689–692.
- Kubisz P, Bartošová L, Ivanková J, et al. Is gas6 protein associated with sticky platelet syndrome? Clin Appl Thromb Hemost. 2010;16(6):701–704.
- Kubisz P, Ivanková J, Škereňová M, et al. The prevalence of the platelet glycoprotein VI polymorphisms in patients with sticky platelet syndrome and ischemic stroke. Hematology. 2012;17(6):355–362.
- Sokol J, Biringer K, Škereňová M, et al. Platelet aggregation abnormalities in patients with fetal losses: the GP6 gene polymorphism. Fertil Steril. 2012;98(5):1170–1174.
- Kotuličová D, Chudý P, Škereňová M, et al. Variability of GP6 gene in patients with sticky platelet syndrome and deep venous thrombosis and/or pulmonary embolism. Blood Coagul Fibrinolysis. 2012;23(6):543–547.
- Sokol J, Skerenova M, Ivankova J, et al. Association of genetic variability in selected genes in patients with deep vein thrombosis and platelet hyperaggregability. Clin Appl Thromb Hemost. 2018;24(7):1027–1032.
- Czajka P, Fitas A, Jakubik D, et al. MicroRNA as potential biomarkers of platelet function on antiplatelet therapy: a review. Front Physiol. 2021;12:652579.
- Garcia A, Dunoyer-Geindre S, Fontana P. Do miRNAs have a role in platelet function regulation? Hamostaseologie. 2021;41(3):217–224.
- Vadelova L, Skerenova M, Ivankova J, et al. MicroRNA and hyperaggregability of platelets in women with sticky platelet syndrome and pregnancy complications. Bratisl Lek Listy. 2020;121(10):700–704.
- Burke N, Flood K, Murray A, et al. Platelet reactivity changes significantly throughout all trimesters of pregnancy compared with the nonpregnant state: a prospective study. Bjog. 2013;120(13):1599–1604.
- Blomqvist LRF, Strandell AM, Baghaei F, et al. Platelet aggregation in healthy women during normal pregnancy - a longitudinal study. Platelets. 2019;30(4):438–444.
- Hayashi M, Kiumi F, Mitsuya K. Changes in platelet ATP secretion and aggregation during pregnancy and in preeclampsia. Am J Med Sci. 1999;318(2):115–121.
- Rubak P, Villadsen K, Hvas AM. Reference intervals for platelet aggregation assessed by multiple electrode platelet aggregometry. Thromb Res. 2012;130(3):420–423.
- Coleman JR, Moore EE, Kelher MR, et al. Female platelets have distinct functional activity compared with male platelets: implications in transfusion practice and treatment of trauma-induced coagulopathy. J Trauma Acute Care Surg. 2019;87(5):1052–1060.
- Santilli F, Vazzana N, Liani R, et al. Platelet activation in obesity and metabolic syndrome. Obes Rev. 2012;13(1):27–42.
- Rocke AS, Paterson GG, Barber MT, et al. Thromboelastometry and platelet function during acclimatization to high altitude. Thromb Haemost. 2018;118(1):63–71.
- Laursen MA, Larsen JB, Larsen KM, et al. Platelet function in patients with septic shock. Thromb Res. 2020;185:33–42.
- Assinger A, Schrottmaier WC, Salzmann M, et al. Platelets in Sepsis: an update on experimental models and clinical data. Front Immunol. 2019;10:1687.
- Santilli F, Simeone P, Liani R, et al. Platelets and diabetes mellitus. Prostaglandins Other Lipid Mediat. 2015;120:28–39.
- Rodriguez BAT, Johnson AD. Platelet measurements and type 2 diabetes: investigations in two population-based cohorts. Front Cardiovasc Med. 2020;7:118.
- Ilardi F, Gargiulo G, Paolillo R, et al. Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome. J Cardiovasc Med. 2020;21(9):660–666.
- Vona R, Di Franco M, Gambardella L, et al. Potential role of platelets for atherosclerotic events in rheumatoid arthritis. FEBS Open Bio. 2018;8(12):1888–1896.
- Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, et al. Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int. 2011;31(2):153–164.
- Scherlinger M, Sisirak V, Richez C, et al. New insights on platelets and platelet-derived microparticles in systemic lupus erythematosus. Curr Rheumatol Rep. 2017;19(8):48.
- Nhek S, Clancy R, Lee KA, et al. Activated platelets induce endothelial cell activation via an interleukin-1β pathway in systemic lupus erythematosus. Arterioscler Thromb Vasc Biol. 2017;37(4):707–716.
- Avram S, Lupu A, Angelescu S, et al. Abnormalities of platelet aggregation in chronic myeloproliferative disorders. J Cell Mol Med. 2001;5(1):79–87.
- Hvas AM, Favaloro EJ. Platelet function analyzed by light transmission aggregometry. Methods Mol Biol. 2017;1646:321–331.
- Koltai K, Kesmarky G, Feher G, et al. platelet aggregometry testing: molecular mechanisms, techniques and clinical implications. Int J Mol Sci. 2017;18(8):1803.
- Lordkipanidzé M. Platelet Function Tests. Semin Thromb Hemost. 2016;42(3):258–267.
- Gross L, Aradi D, Sibbing D. Platelet function testing in patients on antiplatelet medications. Semin Thromb Hemost. 2016;42(3):306–320.
- Gremmel T, Frelinger AL 3rd, Michelson AD. Platelet physiology. Semin Thromb Hemost. 2016;42(3):191–204.
- Hayward CP, Moffat KA, Raby A, et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol. 2010;134(6):955–963.
- Harrison P, Mackie I, Mumford A, et al. British committee for standards in haematology. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol. 2011;155(1):30–44.
- Cattaneo M, Cerletti C, Harrison P, et al., Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH. J Thromb Haemost. 2013;11(6):1183–1189.
- Gresele P. Subcommittee on Platelet Physiology of the International Society on thrombosis and hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost. 2015;13(2):314–322.
- Althaus K, Zieger B, Bakchoul T, et al. THROMKID-Plus Studiengruppe der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) und der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH). Standardization of Light Transmission Aggregometry for Diagnosis of Platelet Disorders: an Inter-Laboratory External Quality Assessment. Thromb Haemost. 2019;119(7):1154–1161.
- Frere C, Kobayashi K, Dunois C, et al. Assessment of platelet function on the routine coagulation analyzer Sysmex CS-2000i. Platelets. 2018;29(1):95–97.
- Brouns SLN, van Geffen JP, Heemskerk JWM. High-throughput measurement of human platelet aggregation under flow: application in hemostasis and beyond. Platelets. 2018;29(7):662–669.
- Munnix ICA, Van Oerle R, Verhezen P, et al. Harmonizing light transmission aggregometry in the Netherlands by implementation of the SSC-ISTH guideline. Platelets. 2021;32(4):516–523.
- James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021;5(1):280–300.
- Marlar RA, Gausman JN. Laboratory testing issues for protein C, protein S, and antithrombin. Int J Lab Hematol. 2014;36(3):289–295.
- Kubisz P, Holly P, Stasko J. Sticky Platelet Syndrome: 35 Years of Growing Evidence. Semin Thromb Hemost. 2019;45(1):61–68.
- Weisman SM, Brunton S. Primary prevention of CVD with aspirin: benefits vs risks. J Fam Pract. 2021;70(6S):S41–6.
- Brighton TA, Eikelboom JW, Mann K, et al. ASPIRE Investigators. Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med. 2012;367(21):1979–1987.
- Saito Y, Kobayashi Y. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention. Cardiovasc Interv Ther. 2020;35(1):44–51.
- Gurbel PA, Fox KAA, Tantry US, et al. Combination antiplatelet and oral anticoagulant therapy in patients with coronary and peripheral artery disease. Circulation. 2019;139(18):2170–2185.
- Granziera S, Cohen AT. VTE primary prevention, including hospitalised medical and orthopaedic surgical patients. Thromb Haemost. 2015;113(6):1216–1223.
- Aimo A, De Caterina R. Aspirin for primary prevention of cardiovascular disease: advice for a decisional strategy based on risk stratification. Anatol J Cardiol. 2020;23(2):70–78.
- Schulman S, Ageno W, Konstantinides SV. Venous thromboembolism: past, present and future. Thromb Haemost. 2017;117(7):1219–1229.
- Abe K, Kuklina EV, Hooper WC, et al. Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States. Semin Perinatol. 2019;43(4):200–204.
- Dimitriadis E, Menkhorst E, Saito S, et al. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98.
- Campello E, Spiezia L, Adamo A, et al. Thrombophilia, risk factors and prevention. Expert Rev Hematol. 2019;12(3):147–158.
- Zöller B, Svensson PJ, Dahlbäck B, et al. Genetic risk factors for venous thromboembolism. Expert Rev Hematol. 2020;13(9):971–981.